Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

IJPRT. 2014; 4(2): 01-04


Evaluation of Antimitotic Activity of Mukia maderaspatana L. Leaf Extract in Allium cepa Root Model

M.Kavitha& 1645;, P.T.Srinivasan, G. Renuga and L.V.Jayakumar.




Abstract

Mukia maderaspatana L. (called as “musumusukkai” in Tamil) is an important medicinal plant used as a herbal drug in
cough and cold by folklores. The present study was carried out to evaluate the cytotoxic effect of various leaf extract
(hexane, chloroform, acetone, ethylacetate, ethanol and aqueous) of M. Maderaspatana on meristematic cells of root tips of
Allium cepa. Locally available Allium cepa bulbs were grown in 50ml water for 48 hours for root sprouting and then they
were exposed to 10mg/ml concentration of each of the extract separately for 48 hours. Tap water was used as control and the
cytotoxic drug methotrexate (1mg/ml) served as standard. The results indicated that the mitotic index and root growth rate of
A.cepa were considerably decreased in treated in comparison to the control. Also the most effective extract was found to be
acetone which reduced the mitotic index significantly. Its EC50 was found to be 10 mg/ml. Further, it was able to induce a
high DNA fragmentation followed by leaf ethanol extract in Allium cepa root tip cells.

Key words: Mukia maderaspatana, Allium cepa, methotrexate, mitotic index, EC50, DNA fragmentation






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.